1–2 of 2 results for ciliary neurotrophic factor
Post Hoc Analyses of Responder Status in Phase 3 Studies of Ciliary Neurotrophic Factor–Producing Revakinagene Taroretcel in People With Macular Telangiectasia Type 2
John A. Wells, MD, FACS
Updates from the Field
2024
Phase 2 Trial of Ciliary Neurotrophic Factor for Macular Telangiectasia
2017